Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy

Kendrick Yim(Brigham and Women's Hospital), Kevin Melnick(Brigham and Women's Hospital), Sarah L. Mott(University of Iowa), Filipe L.F. Carvalho(Brigham and Women's Hospital), Affan Zafar(Brigham and Women's Hospital), Timothy N. Clinton(Brigham and Women's Hospital), Matthew Mossanen(Brigham and Women's Hospital), Graeme S. Steele(Brigham and Women's Hospital), Michelle S. Hirsch(Brigham and Women's Hospital), Natalie M. Rizzo(Brigham and Women's Hospital), Chin‐Lee Wu(Massachusetts General Hospital), Kent W. Mouw(Dana-Farber Cancer Institute), Matthew Wszolek(Massachusetts General Hospital), Keyan Salari(Massachusetts General Hospital), Adam S. Feldman(Massachusetts General Hospital), Adam S. Kibel(Brigham and Women's Hospital), Michael A. O’Donnell(University of Iowa), Mark A. Preston(Brigham and Women's Hospital)
Urologic Oncology Seminars and Original Investigations
September 9, 2023
10.1016/j.urolonc.2023.06.018
Cited by 28

Abstract

Related Papers

No related papers found

Powered by citation graph analysis